Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Doumont

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|January 1, 1984
Methodology required to show clinical differences between benzodiazepinesM Ansseau, A Doumont, S Diricq
Acta Psychiatrica Belgica|September 1, 1983
Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disordersM Ansseau, A Doumont, D Thiry, et al.
The New England Journal of Medicine|February 23, 1984
A long-acting benzodiazepine is more effective in divided dosesM Ansseau, A Doumont, R von Frenckell, et al.
Psychopharmacology|January 1, 1984
Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepamM Ansseau, A Doumont, R von Frenckell, et al.
Acta Psychiatrica Belgica|July 1, 1982
[Compatibility between AMDP scales and "Research Diagnostic Criteria" (RDC) for the diagnosis of endogenous depression]A Doumont, G Charles, J Mirel, et al.
Acta Psychiatrica Belgica|July 1, 1982
[The necessity for standardized diagnosis in research in biological psychiatry. Attempted integration of "Research Diagnostic Criteria" into the AMDP system]M Ansseau, A Doumont, J L Cerfontaine, et al.
Psychopharmacology|January 1, 1985
Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over designM Ansseau, A Doumont, D Thiry, et al.
Acta Psychiatrica Belgica|January 1, 1983
Interest of 5-hydroxytryptophan (5-HTP) as a neuroendocrine marker in depressive illness. A negative reportM Ansseau, A Doumont, D Thiry, et al.
Psychiatry Research|July 1, 1984
Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot studyM Ansseau, M Scheyvaerts, A Doumont, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|April 1, 1985
[Value of the sleep EEG as a biological marker of depressive states. Comparison with 3 neuroendocrine tests]M Ansseau, M Scheyvaerts, A Doumont, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|January 1, 1984
Methodology required to show clinical differences between benzodiazepinesM Ansseau, A Doumont, S Diricq
Acta Psychiatrica Belgica|September 1, 1983
Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disordersM Ansseau, A Doumont, D Thiry, et al.
The New England Journal of Medicine|February 23, 1984
A long-acting benzodiazepine is more effective in divided dosesM Ansseau, A Doumont, R von Frenckell, et al.
Psychopharmacology|January 1, 1984
Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepamM Ansseau, A Doumont, R von Frenckell, et al.
Acta Psychiatrica Belgica|July 1, 1982
[Compatibility between AMDP scales and "Research Diagnostic Criteria" (RDC) for the diagnosis of endogenous depression]A Doumont, G Charles, J Mirel, et al.
Acta Psychiatrica Belgica|July 1, 1982
[The necessity for standardized diagnosis in research in biological psychiatry. Attempted integration of "Research Diagnostic Criteria" into the AMDP system]M Ansseau, A Doumont, J L Cerfontaine, et al.
Psychopharmacology|January 1, 1985
Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over designM Ansseau, A Doumont, D Thiry, et al.
Acta Psychiatrica Belgica|January 1, 1983
Interest of 5-hydroxytryptophan (5-HTP) as a neuroendocrine marker in depressive illness. A negative reportM Ansseau, A Doumont, D Thiry, et al.
Psychiatry Research|July 1, 1984
Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot studyM Ansseau, M Scheyvaerts, A Doumont, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|April 1, 1985
[Value of the sleep EEG as a biological marker of depressive states. Comparison with 3 neuroendocrine tests]M Ansseau, M Scheyvaerts, A Doumont, et al.
Pageof 2